As an Independent Prognostic Factor, EZH2 Promotes Gastric Cancer Progression via Akt Pathway

被引：0
|
作者：
Tan, Cong [1 ]
Xu, Mi-die [1 ]
Ni, Shujuan [1 ]
Weng, Weiwei [1 ]
Sun, Xiangjie [1 ]
Zhang, Qiongyan [1 ]
Huang, Dan [1 ]
Sheng, Weiqi [1 ]
Du, Xiang [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
805
引用
收藏
页码：203A / 203A
页数：1
相关论文
共 50 条
  • [21] Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
    Wagener, Nina
    Macher-Goeppinger, Stephan
    Pritsch, Maria
    Huesing, Johannes
    Hoppe-Seyler, Karin
    Schirmacher, Peter
    Pfitzenmaier, Jesco
    Haferkamp, Axel
    Hoppe-Seyler, Felix
    Hohenfellner, Markus
    BMC CANCER, 2010, 10
  • [22] EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
    Fumihiko Murai
    Daizo Koinuma
    Aya Shinozaki-Ushiku
    Masashi Fukayama
    Kohei Miyaozono
    Shogo Ehata
    Cell Discovery, 1
  • [23] EZH2 promotes progression of small cell lung cancer by suppressing the TGF-β-Smad-ASCL1 pathway
    Murai, Fumihiko
    Koinuma, Daizo
    Shinozaki-Ushiku, Aya
    Fukayama, Masashi
    Miyaozono, Kohei
    Ehata, Shogo
    CELL DISCOVERY, 2015, 1
  • [24] Diabetes Promotes Myocardial Fibrosis via AMPK/ EZH2/PPAR-γ Signaling Pathway
    Li, Shan-Shan
    Pan, Lu
    Dang, Shipeng
    Wang, Ru-Xing
    DIABETES & METABOLISM JOURNAL, 2024, 48 (06) : 1181 - 1182
  • [25] Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway
    Wang, Lan
    Ouyang, Fei
    Liu, Xiaobo
    Wu, Shu
    Wu, Hong-mei
    Xu, Yuandong
    Wang, Bin
    Zhu, Jinrong
    Xu, Xuehu
    Zhang, Liang
    ONCOTARGET, 2016, 7 (04) : 3791 - 3805
  • [26] L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer
    Dong-liang Chen
    Zhao-lei Zeng
    Jing Yang
    Chao Ren
    De-shen Wang
    Wen-jing Wu
    Rui-hua Xu
    Journal of Hematology & Oncology, 6
  • [27] Diabetes Promotes Myocardial Fibrosis via AMPK/ EZH2/PPAR-γ Signaling Pathway
    Li, Shan-Shan
    Pan, Lu
    Zhang, Zhen-Ye
    Zhou, Meng-Dan
    Chen, Xu-Fei
    Qian, Ling-Ling
    Dai, Min
    Lu, Juan
    Yu, Zhi-Ming
    Dang, Shipeng
    Wang, Ru-Xing
    DIABETES & METABOLISM JOURNAL, 2024, 48 (04) : 716 - 729
  • [28] Update of research on the role of EZH2 in cancer progression
    Shen, Liang
    Cui, Jing
    Liang, Shumei
    Pang, Yingxin
    Liu, Peishu
    ONCOTARGETS AND THERAPY, 2013, 6 : 321 - 324
  • [29] lncRNA HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer via EZH2
    Qian, Liyu
    Fei, Qiaoman
    Zhang, Haoran
    Qiu, Manman
    Zhang, Bo
    Wang, Qin
    Yu, Yang
    Guo, Chenxu
    Ren, Yu
    Mei, Mei
    Zhang, Ling
    Zhu, Yu
    Yang, Bing
    DNA AND CELL BIOLOGY, 2020, 39 (12) : 2166 - 2173
  • [30] Osteopontin Promotes EZH2 Expression and Tumor Progression in Nasopharyngeal Carcinoma
    Ma, Renqiang
    Luo, Xi
    Feng, Shaoyan
    Li, Jian
    Fan, Yunping
    Wen, Weiping
    Li, Huabin
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2014, 76 (05): : 273 - 281
12345